Anti-malarial Drugs Reduce Vascular Smooth Muscle Cell Proliferation via Activation of AMPK and Inhibition of Smad3 Signaling

키워드

참고문헌 (35)

1. Owens GK, "Molecular regulation of vascular smooth muscle cell differentiation in development and disease", Physiol Rev, 84, pp.767~801 (2004)
2. Bennett MR, "Vascular smooth muscle cells in atherosclerosis", Circ Res, 118, pp.692~702 (2016)
3. Durham AL, "Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness", Cardiovasc Res, 114, pp.590~600 (2018)
4. Fuster JJ, "Control of cell proliferation in atherosclerosis: insights from animal models and human studies", Cardiovasc Res, 86, pp.254~264 (2010)
5. Rudijanto A, "The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis", Acta Med Indones, 39, pp.86~93 (2007)
6. Rensen SS, "Regulation and characteristics of vascular smooth muscle cell phenotypic diversity", Neth Heart J, 15, pp.100~108 (2007)
7. Golden EB, "Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors", Neurosurg Focus, 38, pp.E12~ (2015)
8. Mauthe M, "Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion", Autophagy, 14, pp.1435~1455 (2018)
9. Solomon VR, "Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies", Eur J Pharmacol, 625, pp.220~233 (2009)
10. Lee SJ, "The role of antimalarial agents in the treatment of SLE and lupus nephritis", Nat Rev Nephrol, 7, pp.718~729 (2011)
11. Rynes RI, "Antimalarial drugs in the treatment of rheumatological diseases", 36, pp.799~805 (1997)
12. Sharma TS, "Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients", J Am Heart Assoc, 5, pp.e002867~ (2016)
13. Long L, "Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation", Circ Res, 112, pp.1159~1170 (2013)
14. Chen D, "Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype", Nat Commun, 9, pp.873~ (2018)
15. Mihaylova MM, "The AMPK signalling pathway coordinates cell growth, autophagy and metabolism", Nat Cell Biol, 13, pp.1016~1023 (2011)
16. Sanders MJ, "Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade", Biochem J, 403, pp.139~148 (2007)
17. Rubin LJ, "Metabolic activation of AMP kinase in vascular smooth muscle", J Appl Physiol (1985), 98, pp.296~306 (2005)
18. Motoshima H, "AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer", J Physiol, 574, pp.63~71 (2006)
19. Stone JD, "AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury", Am J Physiol Heart Circ Physiol, 304, pp.H369~H381 (2013)
20. Stone JD, "Inhibition of vascular smooth muscle growth via signaling crosstalk between AMP-activated protein kinase and cAMP-dependent protein kinase", Front Physiol, 3, pp.409~ (2012)
21. Zou MH, "AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function", Clin Exp Pharmacol Physiol, 35, pp.535~545 (2008)
22. Biernacka A, "TGF-β signaling in fibrosis", Growth Factors, 29, pp.196~202 (2011)
23. Pardali E, "TGFβ signaling and cardiovascular diseases", Int J Biol Sci, 8, pp.195~213 (2012)
24. Akhurst RJ, "Targeting the TGFβ signalling pathway in disease", Nat Rev Drug Discov, 11, pp.790~811 (2012)
25. Hneino M, "Density-dependent shift of transforming growth factorbeta-1 from inhibition to stimulation of vascular smooth muscle cell growth is based on unconventional regulation of proliferation, apoptosis and contact inhibition", J Vasc Res, 46, pp.85~97 (2009)
26. Samarakoon R, "TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)", EGFR(Y845) and Rho, J Mol Cell Cardiol, pp.2008, 44[DOI]
27. Suwanabol PA, "Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signalregulated kinase mitogen-activated protein kinases pathways", J Vasc Surg, 56, pp.446~454 (2012)
28. Tsai S, "TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation", Am J Physiol Heart Circ Physiol, 297, pp.H540~H549 (2009)
29. Nam D, "A model of disturbed flow-induced atherosclerosis in mouse carotid artery by partial ligation and a simple method of RNA isolation from carotid endothelium", J Vis Exp, pp.1861~ (2010)
30. Stone JD, "AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: implications for a Smad-3-dependent mechanism", Am J Physiol Heart Circ Physiol, 309, pp.H1251~H1259 (2015)
31. Sperber K, "Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells", J Rheumatol, 20, pp.803~808 (1993)
32. Wozniacka A, "Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients", Lupus, 15, pp.268~275 (2006)
33. Fan C, "Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells", Bioorg Med Chem, 14, pp.3218~3222 (2006)
34. Zheng Y, "Chloroquine inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis", Cancer Invest, 27, pp.286~292 (2009)
35. Monma H, "Chloroquine augments TRAILinduced apoptosis and induces G2", M phase arrest in human pancreatic cancer cells, 2018, pp.13, e0193990~

관련 논문AI추천